| For: | Ozkok A, Yildiz A. Hepatitis C virus associated glomerulopathies. World J Gastroenterol 2014; 20(24): 7544-7554 [PMID: 24976695 DOI: 10.3748/wjg.v20.i24.7544] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v20/i24/7544.htm |
| Number | Citing Articles |
| 1 |
I. Yu. Golovach, Ye. D. Yegudina. Cryoglobulinemia and cryoglobulinemic vasculitis: etiological aspects and pathophysiological associations. Modern Rheumatology Journal 2020; 14(1) doi: 10.14412/1996-7012-2020-1-78-84
|
| 2 |
Joan Martínez-Campreciós, Mar Riveiro-Barciela, Raquel Muñoz-Gómez, María-Carlota Londoño, Mercé Roget, Miguel Ángel Serra, Desamparados Escudero-García, Laura Purchades, Manuel Rodríguez, Juan E. Losa-García, María L. Gutiérrez, Isabel Carmona, Javier García-Samaniego, Luís Morano, Ignacio Martín-Granizo, Marta Montero-Alonso, Martín Prieto, Manuel Delgado, Natalia Ramos, María A. Azancot, Francisco Rodríguez-Frías, Maria Buti. Long-term follow-up of HCV-infected patients with end-stage chronic kidney disease after sustained virological response with direct-acting antiviral therapy. Gastroenterología y Hepatología 2023; 46(8) doi: 10.1016/j.gastrohep.2022.12.004
|
| 3 |
Muhammad Umair Khan, Mohamed Ibrahim Mahmoud, Adeel A. Butt. Hepatitis c virus and chronic kidney disease. Expert Review of Gastroenterology & Hepatology 2020; 14(7) doi: 10.1080/17474124.2020.1776111
|
| 4 |
Riccardo Nevola, Luca Rinaldi, Letizia Zeni, Ciro Romano, Aldo Marrone, Raffaele Galiero, Pia Clara Pafundi, Carlo Acierno, Erica Vetrano, Luigi Elio Adinolfi. Changes in clinical scenarios, management, and perspectives of patients with chronic hepatitis C after viral clearance by direct-acting antivirals. Expert Review of Gastroenterology & Hepatology 2021; 15(6) doi: 10.1080/17474124.2021.1877136
|
| 5 |
J. Levitsky, R.N. Formica, R.D. Bloom, M. Charlton, M. Curry, J. Friedewald, J. Friedman, D. Goldberg, S. Hall, M. Ison, T. Kaiser, D. Klassen, G. Klintmalm, J. Kobashigawa, A. Liapakis, K. O’Conner, P. Reese, D. Stewart, N. Terrault, N. Theodoropoulos, J. Trotter, E. Verna, M. Volk. The American Society of Transplantation Consensus Conference on the Use of Hepatitis C Viremic Donors in Solid Organ Transplantation. American Journal of Transplantation 2017; 17(11) doi: 10.1111/ajt.14381
|
| 6 |
Andrea Angeletti, Chiara Cantarelli, Paolo Cravedi. HCV-Associated Nephropathies in the Era of Direct Acting Antiviral Agents. Frontiers in Medicine 2019; 6 doi: 10.3389/fmed.2019.00020
|
| 7 |
Qiao-Yan Guo, Man Wu, Yang-Wei Wang, Guang-Dong Sun. Hepatitis C virus-associated cryoglobulinemia with membrano-proliferative glomerulonephritis treated with prednisolone and interferon: A case report. Experimental and Therapeutic Medicine 2017; 14(2) doi: 10.3892/etm.2017.4671
|
| 8 |
|
| 9 |
Stephanie M. Rutledge, Raymond T. Chung, Meghan E. Sise. Treatment of hepatitis C virus infection in patients with mixed cryoglobulinemic syndrome and cryoglobulinemic glomerulonephritis. Hemodialysis International 2018; 22(S1) doi: 10.1111/hdi.12649
|
| 10 |
Florian Gunnar Scurt, Katrin Bose, Ali Canbay, Peter R Mertens, Christos Chatzikyrkou. Ursachen der chronischen Nierenschädigung in Patienten mit Lebererkrankungen – Pathophysiologie und Therapiemöglichkeiten. Zeitschrift für Gastroenterologie 2021; 59(06) doi: 10.1055/a-1402-1502
|
| 11 |
Zhenzhen Zhang, Liang Rong, Yi-Ping Li. Flaviviridae Viruses and Oxidative Stress: Implications for Viral Pathogenesis. Oxidative Medicine and Cellular Longevity 2019; 2019 doi: 10.1155/2019/1409582
|
| 12 |
Eva Wu, Nadine Koch, Friederike Bachmann, Marten Schulz, Evelyn Seelow, Ulrike Weber, Johannes Waiser, Fabian Halleck, Mirko Faber, Claus-Thomas Bock, Kai-Uwe Eckardt, Klemens Budde, Jörg Hofmann, Peter Nickel, Mira Choi. Risk Factors for Hepatitis E Virus Infection and Eating Habits in Kidney Transplant Recipients. Pathogens 2023; 12(6) doi: 10.3390/pathogens12060850
|
| 13 |
Satoshi Takakusagi, Ken Sato, Yuhei Suzuki, Yuichi Yamazaki, Takashi Kosone, Satoru Kakizaki, Motoyasu Kusano, Hitoshi Takagi. Improvement of Proteinuria due to Combination Therapy with Daclatasvir and Asunaprevir in Hepatitis C Virus-associated Renal Disease without Cryoglobulinemia. Internal Medicine 2018; 57(15) doi: 10.2169/internalmedicine.9624-17
|
| 14 |
Hui-Chun Li, Shih-Yen Lo. Hepatitis C virus: Virology, diagnosis and treatment. World Journal of Hepatology 2015; 7(10): 1377-1389 doi: 10.4254/wjh.v7.i10.1377
|
| 15 |
Q.‐t. Huang, Q. Huang, M. Zhong, S.‐s. Wei, W. Luo, F. Li, Y.‐h. Yu. Chronic hepatitis C virus infection is associated with increased risk of preterm birth: a meta‐analysis of observational studies. Journal of Viral Hepatitis 2015; 22(12) doi: 10.1111/jvh.12430
|
| 16 |
M L Zubkin, V I Chervinko, Yu V Ovchinnikov, E V Kryukov, O N Kotenko. Chronic hepatitis C virus infection: An internist’s opinion (Part 1). Terapevticheskii arkhiv 2016; 88(10) doi: 10.17116/terarkh2016886105-113
|
| 17 |
Weigang Zhang, Qiyu He, Hao Wang, Wanyun Gong, Lei Qin, Yunjie Lu, Yuting Wang, Wei Chen, Ling Wang, Wei He, Lin Wang, Yu Wang. Hepatitis E virus infection and renal injury in non-immunocompromised host: clinical investigation and rabbit model study. Frontiers in Cellular and Infection Microbiology 2025; 15 doi: 10.3389/fcimb.2025.1583006
|
| 18 |
Soolmaz Khansalar. IFN-γ, IL-17, IL-22+ CD4+ subset in patients with hepatitis C virus and correlation with clinical factor. American Journal of Clinical and Experimental Immunology 2024; 13(1) doi: 10.62347/DMJC6311
|
| 19 |
E. Schrezenmeier, K. Wu, F. Halleck, L. Liefeldt, S. Brakemeier, F. Bachmann, S. Kron, K. Budde, M. Duerr. Successful Recovery of Acute Renal Transplant Failure in Recurrent Hepatitis C Virus–Associated Membranoproliferative Glomerulonephritis. American Journal of Transplantation 2017; 17(3) doi: 10.1111/ajt.14091
|
| 20 |
Ryan W. Bonner, Vanessa Moreno, Koyal Jain. Infection-Associated Glomerulonephritis. Advances in Kidney Disease and Health 2024; 31(3) doi: 10.1053/j.akdh.2024.01.001
|
| 21 |
Chen-Hua Liu, Jou-Wei Lin, Chun-Jen Liu, Tung-Hung Su, Jo-Hsuan Wu, Tai-Chung Tseng, Pei-Jer Chen, Jia-Horng Kao. Long-term Evolution of Estimated Glomerular Filtration Rate in Patients With Antiviral Treatment for Hepatitis C Virus Infection. Clinical Gastroenterology and Hepatology 2023; 21(2) doi: 10.1016/j.cgh.2022.01.050
|
| 22 |
Matteo Passerini, Monica Schiavini, Carlo F. Magni, Simona Landonio, Fosca Niero, Simone Passerini, Alessandro L. Croci, Matteo Bolis, Valentina Scalzi, Guido Gubertini, Elena D. Ricci, Massimo Galli, Giuliano Rizzardini. Are direct-acting antivirals safe and effective in hepatitis C virus-cryoglobulinemia? virological, immunological, and clinical data from a real-life experience. European Journal of Gastroenterology & Hepatology 2018; 30(10) doi: 10.1097/MEG.0000000000001239
|
| 23 |
Anjali A. Satoskar, Samir V. Parikh, Tibor Nadasdy. Epidemiology, pathogenesis, treatment and outcomes of infection-associated glomerulonephritis. Nature Reviews Nephrology 2020; 16(1) doi: 10.1038/s41581-019-0178-8
|
| 24 |
Jagadeswar Kakumani, Krishna Geetha Narne, Amukthamalyada Koduri, Prem Balaji Reddy Lankapothu, Magesh Kumar S. Hepatitis C-Induced Immunoglobulin A (IgA) Nephropathy: An Uncommon Cause of Hematuria. Cureus 2024; doi: 10.7759/cureus.70168
|
| 25 |
Joshua D. Long, Stephanie M. Rutledge, Meghan E. Sise. Autoimmune Kidney Diseases Associated with Chronic Viral Infections. Rheumatic Disease Clinics of North America 2018; 44(4) doi: 10.1016/j.rdc.2018.06.006
|
| 26 |
Ida V. Stalund, Heidi Grønseth, Finn P. Reinholt, Einar Svarstad, Hans-Peter Marti, Sabine Leh. Chronic Kidney Disease from Polyvinylpyrrolidone Deposition in Persons with Intravenous Drug Use. Clinical Journal of the American Society of Nephrology 2022; 17(4) doi: 10.2215/CJN.13681021
|
| 27 |
Anne C. Moorman, Xin Tong, Philip R. Spradling, Loralee B. Rupp, Stuart C. Gordon, Mei Lu, Eyasu H. Teshale, Joseph A. Boscarino, Connie M. Trinacty, Mark A. Schmidt, Fujie Xu, Scott D. Holmberg. Prevalence of Renal Impairment and Associated Conditions Among HCV-Infected Persons in the Chronic Hepatitis Cohort Study (CHeCS). Digestive Diseases and Sciences 2016; 61(7) doi: 10.1007/s10620-016-4199-x
|
| 28 |
Lucia Taramasso, Antonio Di Biagio, Francesca Bovis, Laura Ambra Nicolini, Andrea Antinori, Laura Milazzo, Salvatore Sollima, Guido Gubertini, Fosca Niero, Annalisa Saracino, Raffaele Bruno, Vanni Borghi, Francesca Montagnani, Annamaria Cattelan, Hamid Hasson, Gloria Taliani, Antonella D’Arminio Monforte, Claudio Mastroianni, Giovanni Di Perri, Sara Bigoni, Massimo Puoti, Angiola Spinetti, Andrea Gori, Nicola Boffa, Bruno Cacopardo, Andrea Giacometti, Giustino Parruti, Vincenzo Vullo, Antonio Chirianni, Elisabetta Teti, Caterina Pasquazzi, Daniela Segala, Massimo Andreoni, Chen-Hua Liu. Trend of estimated glomerular filtration rate during ombistasvir/paritaprevir/ritonavir plus dasabuvir ± ribavirin in HIV/HCV co-infected patients. PLOS ONE 2018; 13(2) doi: 10.1371/journal.pone.0192627
|
| 29 |
Kuo-Hsiung Shu, Cheng-Hsu Chen, Ming-Ju Wu, Shang-Feng Tsai. Clinical outcomes of renal transplant recipients with and without post-transplant post-infectious glomerulonephritis: a propensity score-matched analysis. International Journal of Surgery 2026; 112(2) doi: 10.1097/JS9.0000000000003751
|
| 30 |
Aalam Sohal, Carol Singh, Akshita Bhalla, Harsimran Kalsi, Marina Roytman. Renal Manifestations of Chronic Hepatitis C: A Review. Journal of Clinical Medicine 2024; 13(18) doi: 10.3390/jcm13185536
|
| 31 |
Yiming Ding, Tonglei Zhao, Jie Ji, Zejun Wang, Dakun Zhang, Zhicheng Ye, Ming Chen, Weipu Mao, Jianping Wu. Association between hepatitis C virus and overactive bladder: a cross-sectional study based on the 2013–2018 NHANES. BMC Urology 2026; 26(1) doi: 10.1186/s12894-026-02170-w
|
| 32 |
Hongfeng Huang, Huanna Tang, Hao Deng, Jia Shen, Qin Zhou, Wenqing Xie, Jianyong Wu, Jianghua Chen. Treatment of chronic hepatitis C viral infection with sofosbuvir and daclatasvir in kidney transplant recipients. Transplant Infectious Disease 2019; 21(1) doi: 10.1111/tid.13018
|
| 33 |
Che-Pin Chang, Yuan-Chih Su, Mei-Chen Lin, Sheng-Teng Huang. Chinese Herbal Medicine Ameliorated the Development of Chronic Kidney Disease in Patients with Chronic Hepatitis C: A Retrospective Population-Based Cohort Study. Evidence-Based Complementary and Alternative Medicine 2019; 2019 doi: 10.1155/2019/5319456
|
| 34 |
Elisa Biliotti, Donatella Palazzo, Francesca Tinti, Maria Domenica D'Alessandro, Rozenn Esvan, Raffaella Labriola, Andrea Cappoli, Ilaria Umbro, Lorenzo Volpicelli, Alessandra Bachetoni, Erica Villa, Anna Paola Mitterhofer, Paola Rucci, Gloria Taliani. HCV cirrhotic patients treated with direct‐acting antivirals: Detection of tubular dysfunction and resolution after viral clearance. Liver International 2021; 41(1) doi: 10.1111/liv.14672
|
| 35 |
Elmukhtar Habas, Khalifa L Farfar, Nada Errayes, Ala M Habas, Mehdi Errayes, Gamal Alfitori, Amnna Rayani, Mohamed Elgara, Aisha H Al Adab, Abdulnaser Elzouki. Hepatitis Virus C-associated Nephropathy: A Review and Update. Cureus 2022; doi: 10.7759/cureus.27322
|
| 36 |
Humberto Bohorquez, Juan C.Q. Velez, Mark Lusco, Jennifer Scheuermann, Ari J. Cohen. Hepatitis C–associated focal proliferative glomerulonephritis in an aviremic recipient of a hepatitis C–positive antibody donor liver. American Journal of Transplantation 2021; 21(8) doi: 10.1111/ajt.16565
|
| 37 |
Jae Hwan Kim, Kyoung-Sun Kim, Hye-Mee Kwon, Sung-Hoon Kim, In-Gu Jun, Jun-Gol Song, Gyu-Sam Hwang. Impact of Chronic Hepatitis C Virus on Acute Kidney Injury After Living Donor Liver Transplantation. Anesthesia & Analgesia 2025; 141(3) doi: 10.1213/ANE.0000000000007253
|
| 38 |
N. B. Gordovskaya, L. V. Kozlovskaya, S. Yu. Milovanova. Cryoglobulinemic vasculitis with renal involvement: A historic aspect of the problem. Terapevticheskii arkhiv 2015; 87(6) doi: 10.17116/terarkh2015876112-117
|
| 39 |
Mohamed A. El-Mokhtar, Mohamed Ismail Seddik, Asmaa Osman, Sara Adel, Essam M. Abdel Aziz, Sahar A. Mandour, Nasreldin Mohammed, Mohamed A. Zarzour, Lobna Abdel-Wahid, Eman Radwan, Ibrahim M. Sayed. Hepatitis E Virus Mediates Renal Injury via the Interaction between the Immune Cells and Renal Epithelium. Vaccines 2020; 8(3) doi: 10.3390/vaccines8030454
|
| 40 |
Sofija Sekulic, Zeljko Mijailovic, Dejan Petrovic, Ruzica Lukic, Marina Jovanovic, Ivan Jovanovic. HCV Infection and Chronic Renal Disease. Serbian Journal of Experimental and Clinical Research 2021; doi: 10.2478/sjecr-2021-0010
|
| 41 |
Qinjie Weng, Xiao Li, Hong Ren, Jingyuan Xie, Xiaoxia Pan, Jing Xu, Nan Chen. Membranous nephropathy associated with hepatitis C virus infection treated with corticosteroids and Ledipasvir-Sofosbuvir: a case report and review of literature. Oncotarget 2017; 8(13) doi: 10.18632/oncotarget.15397
|
| 42 |
Sarah Schrauben, Jeffrey S. Berns. National Kidney Foundation' s Primer on Kidney Diseases. 2018; doi: 10.1016/B978-0-323-47794-9.00023-8
|
| 43 |
Yuval A. Patel, Andrew J. Muir. Treatment of HCV in Renal Disease: Subtle Management Considerations in the Era of Direct-Acting Antivirals. Current Hepatology Reports 2016; 15(4) doi: 10.1007/s11901-016-0319-5
|
| 44 |
Ana Pérez de José, Javier Carbayo, Anna Pocurull, Teresa Bada-Bosch, Clara Maria Cases Corona, Amir Shabaka, Natàlia Ramos Terrada, Laura Martinez Valenzuela, Ana Huerta, Loreto Fernandez Lorente, Tamara Gelen Malek-Marín, Marian Goicoechea. Direct-acting antiviral therapy improves kidney survival in hepatitis C virus-associated cryoglobulinaemia: the RENALCRYOGLOBULINEMIC study. Clinical Kidney Journal 2021; 14(2) doi: 10.1093/ckj/sfz178
|
| 45 |
Busara Songtanin, Kenneth Nugent. Burden, Outcome, and Comorbidities of Extrahepatic Manifestations in Hepatitis C Virus Infection. Biology 2022; 12(1) doi: 10.3390/biology12010023
|
| 46 |
Ahmad Najib Azmi, Soek-Siam Tan, Rosmawati Mohamed. Hepatitis C and kidney disease: An overview and approach to management. World Journal of Hepatology 2015; 7(1): 78-92 doi: 10.4254/wjh.v7.i1.78
|
| 47 |
J. E. Yap, P. Jaiswal, L. Ton, R. Szynkarek, B. M. Attar, S. Gandhi. Successful treatment of chronic hepatitis C infection with crushed elbasvir/grazoprevir administered via a percutaneous endoscopic gastrostomy tube. Journal of Clinical Pharmacy and Therapeutics 2018; 43(5) doi: 10.1111/jcpt.12713
|
| 48 |
Alexia Anastasia Stefania Balta, Mariana Daniela Ignat, Raisa Eloise Barbu, Caterina Dumitru, Diana Sabina Radaschin, Valentin Bulza, Silvia Aura Mateescu Costin, Catalin Pleșea-Condratovici, Liliana Baroiu. Impact of Direct-Acting Antivirals on Extrahepatic Manifestations in Chronic Hepatitis C: A Narrative Review with a Hermeneutic Approach. Healthcare 2025; 13(16) doi: 10.3390/healthcare13161953
|
| 49 |
Carlo Palazzi, Emilio D’Amico, Salvatore D’Angelo, Michele Gilio, Ignazio Olivieri. Rheumatic manifestations of hepatitis C virus chronic infection: Indications for a correct diagnosis. World Journal of Gastroenterology 2016; 22(4): 1405-1410 doi: 10.3748/wjg.v22.i4.1405
|
| 50 |
Nipun Jain, Ravinder Garg, Gagan Preet Singh, Sarabjot Kaur, Sumit Pal Singh Chawla, Preeti Padda. Assessment of Factors Affecting Response of Direct-Acting Antivirals in Chronic Hepatitis C Patients. Annals of African Medicine 2023; 22(4) doi: 10.4103/aam.aam_183_22
|
| 51 |
Ahmed A. Awan, Michel Jadoul, Paul Martin. Hepatitis C in Chronic Kidney Disease: An Overview of the KDIGO Guideline. Clinical Gastroenterology and Hepatology 2020; 18(10) doi: 10.1016/j.cgh.2019.07.050
|
| 52 |
Abd El-Fattah B. M. El-Beltagy, Gamal Mohamed, Lashin Saad Ali, Ahmed A. El-Mansy, Mona F.M. Soliman, Abdelalim A. Gadallah, Reham A. Ghanem, Amany Attaallah. Propolis extract attenuates cisplatin-induced nephrotoxicity in female rats and their offspring. Egyptian Journal of Basic and Applied Sciences 2025; 12(1) doi: 10.1080/2314808X.2024.2446871
|
| 53 |
Raffaele Dell’Acqua, Giuseppina De Vita, Andrea Procopio, Michele Milella, Annalisa Saracino, Gioacchino Angarano. Renal function changes in HCV-infected patients with chronic kidney disease during and after treatment with direct antiviral agents. Digestive and Liver Disease 2017; 49(10) doi: 10.1016/j.dld.2017.07.008
|
| 54 |
Stanislas Pol, Lucia Parlati, Michel Jadoul. Hepatitis C virus and the kidney. Nature Reviews Nephrology 2019; 15(2) doi: 10.1038/s41581-018-0081-8
|
| 55 |
UEG Week 2019 Poster Presentations. United European Gastroenterology Journal 2019; 7(S8) doi: 10.1177/2050640619854671
|
| 56 |
Ilaria Puxeddu, Francesco Ferro, Elena Elefante, Marco Di Battista, Alessandra Della Rossa, Chiara Baldini, Stefano Bombardieri. Infection and Autoimmunity. 2024; doi: 10.1016/B978-0-323-99130-8.00040-4
|
| 57 |
Poonam Mathur, Shyamasundaran Kottilil, Jennifer Husson. Treatment of hepatitis C in renal impairment and renal transplant. Current Treatment Options in Infectious Diseases 2016; 8(4) doi: 10.1007/s40506-016-0089-1
|
| 58 |
Busara Songtanin, Nattanicha Chaisrimaneepan, Roberto Mendóza, Kenneth Nugent. Burden, Outcome, and Comorbidities of Extrahepatic Manifestations in Hepatitis B Virus Infections. Viruses 2024; 16(4) doi: 10.3390/v16040618
|
| 59 |
Aleksandra Starzyńska-Kubicka, Agnieszka Perkowska-Ptasińska, Barbara Górnicka. Membranous glomerulonephritis – a common, unspecific pattern of glomerular injury. Polish Journal of Pathology 2018; 69(3) doi: 10.5114/pjp.2018.79540
|
| 60 |
Emad Samaan, Shahera El-Etreby, Aimun Ahmed, Fatma El-Husseini, Alaa Sabry. The nature and prognosis of renal diseases in chronic hepatitis-C-infected diabetic Egyptian patients: The role of renal biopsy. Diabetes & Metabolic Syndrome: Clinical Research & Reviews 2022; 16(1) doi: 10.1016/j.dsx.2021.102368
|
| 61 |
Shivani Shah, Naima Carter-Monroe, Mohamed G. Atta. Granulomatous interstitial nephritis. Clinical Kidney Journal 2015; 8(5) doi: 10.1093/ckj/sfv053
|
| 62 |
Kirat Gill, Hasmik Ghazinian, Richard Manch, Robert Gish. Hepatitis C virus as a systemic disease: reaching beyond the liver. Hepatology International 2016; 10(3) doi: 10.1007/s12072-015-9684-3
|
| 63 |
Muhammed Mubarak, Syed Muddasir Laeeq, Abbas Ali Tasneem, Nasir Hassan Luck, Zain Majid, Farina M Hanif. Revolution in the diagnosis and management of hepatitis C virus infection in current era. World Journal of Hepatology 2022; 14(4): 647-669 doi: 10.4254/wjh.v14.i4.647
|
| 64 |
Mathurin Pierre Kowo, Sylvain Raoul Simeni Njonnou, Murielle Sonia Mehly Ngninzeko, Firmin Ankouane Andoulo, Antonin Ndjitoyap Ndam, Michelle Tagny Sartre, Vicky Ama Moor, Jeanne Ngongang, François Folefack Kaze. Prevalence and Determinants of Kidney Markers among Subjects with Hepatitis C Virus Infection. Open Journal of Nephrology 2020; 10(02) doi: 10.4236/ojneph.2020.102010
|
| 65 |
|
| 66 |
B. Dussol. Nefropatías glomerulares: orientación diagnóstica y evolución. EMC - Tratado de Medicina 2015; 19(4) doi: 10.1016/S1636-5410(15)74693-3
|
| 67 |
Yu Wang, Ling Yang, Gaosi Xu. New-Onset Acute Interstitial Nephritis Post-SARS-CoV-2 Infection and COVID-19 Vaccination: A Panoramic Review. Journal of Epidemiology and Global Health 2023; 13(4) doi: 10.1007/s44197-023-00159-4
|
| 68 |
Joan Martínez-Campreciós, Mar Riveiro-Barciela, Raquel Muñoz-Gómez, María-Carlota Londoño, Mercé Roget, Miguel Ángel Serra, Desamparados Escudero-García, Laura Purchades, Manuel Rodríguez, Juan E. Losa-García, María L. Gutiérrez, Isabel Carmona, Javier García-Samaniego, Luís Morano, Ignacio Martín-Granizo, Marta Montero-Alonso, Martín Prieto, Manuel Delgado, Natalia Ramos, María A. Azancot, Francisco Rodríguez-Frías, Maria Buti. Long-term follow-up of HCV-infected patients with end-stage chronic kidney disease after sustained virological response with direct-acting antiviral therapy. Gastroenterología y Hepatología (English Edition) 2023; 46(8) doi: 10.1016/j.gastre.2022.12.004
|
| 69 |
Vigneswaran Narayanamurthy, Z. E. Jeroish, K. S. Bhuvaneshwari, Fahmi Samsuri. Hepatitis C virus (HCV) diagnosis via microfluidics. Analytical Methods 2021; 13(6) doi: 10.1039/D0AY02045A
|
| 70 |
Cesare MAZZARO, Endri MAURO, Anna ERMACORA, Paolo DORETTO, Silvia FUMAGALLI, Maurizio TONIZZO, Federica TOFFOLUTTI, Valter GATTEI. Hepatitis C virus-related cryoglobulinemic vasculitis. Minerva Medica 2021; 112(2) doi: 10.23736/S0026-4806.20.07120-7
|
| 71 |
Mayank Jain, Jayanthi Venkataraman. Liver disorders linked with renal dysfunction: A physician's perspective. Gastroenterology, Hepatology and Endoscopy Practice 2023; 3(3) doi: 10.4103/ghep.ghep_31_22
|
| 72 |
Kati Kaartinen, Sauli Vuoti, Eero Honkanen, Eliisa Löyttyniemi, Ravinder Singh, Martti Färkkilä, Chen-Hua Liu. Tubular cell damage may be the earliest sign of renal extrahepatic manifestation caused by Hepatitis C. PLOS ONE 2021; 16(5) doi: 10.1371/journal.pone.0251392
|
| 73 |
Karthik Kovvuru, Nicholas Carbajal, Abhinandan Reddy Pakanati, Charat Thongprayoon, Panupong Hansrivijit, Boonphiphop Boonpheng, Pattharawin Pattharanitima, Voravech Nissaisorakarn, Wisit Cheungpasitporn, Swetha R Kanduri. Renal manifestations of hepatitis E among immunocompetent and solid organ transplant recipients. World Journal of Hepatology 2022; 14(3): 516-524 doi: 10.4254/wjh.v14.i3.516
|
| 74 |
Clodoveo Ferri, Dilia Giuggioli, Michele Colaci. Renal Manifestations of Hepatitis C Virus. Clinics in Liver Disease 2017; 21(3) doi: 10.1016/j.cld.2017.03.005
|
| 75 |
Sanjaya K. Satapathy, Kiran Joglekar, Miklos Z. Molnar, Bilal Ali, Humberto C. Gonzalez, Jason M. Vanatta, James D. Eason, Satheesh P. Nair. Achieving Sustained Virological Response in Liver Transplant Recipients With Hepatitis C Decreases Risk of Decline in Renal Function. Liver Transplantation 2018; 24(8) doi: 10.1002/lt.25059
|
| 76 |
Chen-Hua Liu, Jia-Horng Kao. Pan-genotypic direct-acting antivirals for patients with hepatitis C virus infection and chronic kidney disease stage 4 or 5. Hepatology International 2022; 16(5) doi: 10.1007/s12072-022-10390-z
|
| 77 |
Richard A. Lafayette, Vivek Charu, Richard J. Glassock. Expert Discussion on Immune Complex-Mediated Membranoproliferative Glomerulonephritis: Challenges and Considerations. Advances in Therapy 2025; 42(5) doi: 10.1007/s12325-025-03167-x
|
| 78 |
Nargiza Kurbanova, Rehan Qayyum. Association of Hepatitis C Virus Infection with Proteinuria and Glomerular Filtration Rate. Clinical and Translational Science 2015; 8(5) doi: 10.1111/cts.12321
|
| 79 |
Walid Ahmed Ragab Abdelhamid, Ali Shendi, Mahmoud Zahran, Eman Abd Elbary, Sawsan Fadda. Hepatitis C-related membranoproliferative glomerulonephritis in the era of direct antiviral agents. Brazilian Journal of Nephrology 2022; 44(2) doi: 10.1590/2175-8239-jbn-2020-0148
|
| 80 |
Vincenzo L'Imperio, Andrew Smith, Clizia Chinello, Fabio Pagni, Fulvio Magni. Proteomics and glomerulonephritis: A complementary approach in renal pathology for the identification of chronic kidney disease related markers. PROTEOMICS – Clinical Applications 2016; 10(4) doi: 10.1002/prca.201500075
|
| 81 |
Cesare Mazzaro, Luca Quartuccio, Luigi Elio Adinolfi, Dario Roccatello, Gabriele Pozzato, Riccardo Nevola, Maurizio Tonizzo, Stefano Gitto, Pietro Andreone, Valter Gattei. A Review on Extrahepatic Manifestations of Chronic Hepatitis C Virus Infection and the Impact of Direct-Acting Antiviral Therapy. Viruses 2021; 13(11) doi: 10.3390/v13112249
|
| 82 |
Jean J. Filipov. Therapeutic Plasma Exchange. In Clinical Practice 2026; doi: 10.1007/978-3-032-17275-4_3
|
| 83 |
Michele Moretti, Francesco Ferro, Chiara Baldini, Marta Mosca, Rosaria Talarico. Cryoglobulinemic vasculitis: a 2023 update. Current Opinion in Rheumatology 2024; 36(1) doi: 10.1097/BOR.0000000000000989
|
| 84 |
So Mi Kim, Il Han Song. Hepatitis C virus infection in chronic kidney disease: paradigm shift in management. The Korean Journal of Internal Medicine 2018; 33(4) doi: 10.3904/kjim.2018.202
|
| 85 |
Austin Chan, Lawrence Park, Lauren F Collins, Curtis Cooper, Michael Saag, Douglas Dieterich, Mark Sulkowski, Susanna Naggie. Correlation Between Tenofovir Drug Levels and the Renal Biomarkers RBP-4 and ß2M in the ION-4 Study Cohort. Open Forum Infectious Diseases 2019; 6(1) doi: 10.1093/ofid/ofy273
|
| 86 |
Davide Frumento, Ștefan Țălu. Interaction Between Human Microbiota, Immune System, and Hepatitis C Virus Infection: A Narrative Review. Applied Sciences 2025; 15(6) doi: 10.3390/app15063157
|
| 87 |
Guolin Chen, Wei Zhang, Yiran Ben. Identification of Key Regulators of Hepatitis C Virus-Induced Hepatocellular Carcinoma by Integrating Whole-Genome and Transcriptome Sequencing Data. Frontiers in Genetics 2021; 12 doi: 10.3389/fgene.2021.741608
|
| 88 |
Disaya Chavalitdhamrong, Monthira Maneerattanaporn, Chalermrat Bunchorntavakul. Management of patients with hepatitis C infection and renal disease. World Journal of Hepatology 2015; 7(2): 213-225 doi: 10.4254/wjh.v7.i2.213
|
| 89 |
Warren L. Kupin. Viral-Associated GN: Hepatitis C and HIV. Clinical Journal of the American Society of Nephrology 2017; 12(8) doi: 10.2215/CJN.04320416
|